Will a third dengue vaccine be approved before 2050?
8
390Ṁ5412049
90%
chance
1D
1W
1M
ALL
Dengue fever is an infectious disease caused by dengue viruses and transmitted by mosquitoes. Dengue infects over 300 million people and kills more than 10,000 people each year. As of 2022, there are two commercially available dengue vaccines, called Dengvaxia and Qdenga.
This question will resolve YES if the FDA, EMA, or PMDA approves a dengue vaccine other than Dengvaxia and Qdenga. This includes an Emergency Use Authorization or similar.
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
1,000Related questions
Related questions
Will a dengue vaccine based on TV003/TV005 be approved before 2050?
60% chance
When will Instituto Butantã's Dengue vaccine be approved by Anvisa?
Will a malaria vaccine be deployed to >1M humans in 2023-2024?
94% chance
Will a vaccine for HIV be approved by the FDA by 2030?
76% chance
Will a new tuberculosis vaccine be available by the end of 2032?
72% chance
Will the R21 malaria vaccine be distributed in 15 countries before July 1st, 2025?
48% chance
Will the number of children vaccinated with 3 doses of the R21 malaria vaccine reach 5M before January 1st, 2025?
45% chance
Will development of a universal flu vaccine have made significant progress by 2026?
57% chance
HIV Vaccine fully approved by FDA and commercially available before 2035?
37% chance
Will FDA approve more than 10 new mRNA based vaccines before 2030?
77% chance